This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Ristfor
  • /
  • Accelerated Wound Healing in Diabetic Ulcers by Si...
Clinical trial

Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin (SitaDFU)

Read time: 1 mins
Last updated:1st Mar 2016

The purpose of the study is to test the effect of Sitagliptin on the healing of stable, nonhealing diabetic foot ulcers. This is a randomized placebo-controlled Trial.


Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin
Estimated Enrollment: 40
Study Start Date: March 2016
Estimated Study Completion Date: March 2018
Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)

Arms:
- Active Comparator:
Sitagliptin
- Placebo Comparator: Placebo

Category Value
Study start date 2016-03-01

View full details